Multimin Solution for Injection for Cattle

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

DSU DSU (DSU)
05-12-2023

Active ingredient:

Zinc oxide; Manganese carbonate; Copper(II) carbonate; Sodium selenite

Available from:

Warburton Technology Limited

ATC code:

QA12CX99

INN (International Name):

Zinc oxide; Manganese carbonate; Copper(II) carbonate; Sodium selenite

Dosage:

60, 10, 15, 5 milligram(s)/millilitre

Pharmaceutical form:

Solution for injection

Prescription type:

POM: Prescription Only Medicine as defined in relevant national legislation

Therapeutic group:

Cattle

Therapeutic area:

other mineral products, combinations

Therapeutic indications:

Vitamins and minerals

Authorization status:

Authorised

Authorization date:

2015-07-10

Summary of Product characteristics

                                Health Products Regulatory Authority
22 April 2021
CRN00C20G
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Multimin Solution for Injection for Cattle
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
​
Each ml contains:
​
​
​
ACTIVE SUBSTANCES:
​
​
​
Zinc
60​
mg​
​
(equivalent to zinc oxide: 74.68 mg)
​
​
​
Manganese
10​
mg​
​
(equivalent to manganese carbonate: 20.92 mg)
​
​
​
Copper
15​
mg​
​
(equivalent to copper carbonate; 26.09 mg)
​
​
​
Selenium
5​
mg​
​
(equivalent to sodium selenite: 10.95 mg)
​
​
​
EXCIPIENTS:
​
​
​
Benzyl alcohol (E1519)
​10.4
​
mg
For the full list of excipients, see section 6.1.
​
​
3 PHARMACEUTICAL FORM
Solution for injection
Clear blue solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Supply of trace minerals to correct concurrent clinical or subclinical
deficiencies of selenium, copper, manganese and zinc
which can arise during critical phases of the production or breeding
life cycle.
4.3 CONTRAINDICATIONS
Do not administer intramuscularly.
Do not use in cases of known hypersensitivity to the active substances
or to any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Additional copper, zinc, manganese or selenium should not be
administered at the same time.
Special precautions to be taken by the person administering the
veterinary medicinal product to animals
Health Products Regulatory Authority
22 April 2021
CRN00C20G
Page 2 of 5

This product is HIGHLY concentrated in Selenium.

Due to a potential risk of Selenium toxicity, care should be taken
when handling the product to avoid accidental
self-injection.

The most common manifestations of accidental exposure to selenium in
humans are gastrointestinal and
neurological symptoms, such as nausea, vomiting, tenderness, fatigue
and irritability.

When treati
                                
                                Read the complete document